Fusion and Bacterialcidal Activity of 7-bromo-2-(o-aminophenyl)- 3-amino-Quinazolin-4(3H)-one from 7-bromo,2-(o-aminophenyl)- 1,3-benzoxazin-4(3H)-one
Healthcare Issues · 2026
DOI: 10.58614/hi522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Healthcare Issues, 2026. Verfasst von Osarodion Peter Osarumwense und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Different types of Quinazolinones exhibit a wide spectrum of biological activities including anticancer, antimicrobial, anticonvulsant, antitubercular, anti-inflammatory, anlagesic, estrogenic and antiparkinsonism . Along 5-membered heterocycles thiazolidinone are found to be significant in their anticonvulsant and antimicrobial. Based on these findings the planned to synthesize the title compounds presuming that these chemical entities with thiazolidinone moiety in conjunction with Quinazolinone through imino bridge.
Methods
The compound 2-(o-thiadiaminephenyl)-3-thiadiamine-7-bromo– quinazoline- 4(3H)-one (1), was produce when 2-(o-aminophenyl)-3-amino-6-bromo–Quinazolin-4(3H)- one (0.055 M) was dissolved in minimum amount of dil. HCl in a round bottom flask. Ammonium thiocyanate (0.11 M, 9.68 gm) was then added and the mixture refluxed for 7 hrs. A mixture of 2-(o thiadiaminephenyl)-3-thiadiamine-7-bromo–Quinazolin-4(3H)-one (0.037 M, 16.095 gm) and fused sodium acetate (0.074 M, 6.068 gm) was taken in absolute alcohol (300 ml) and refluxed for 10 hours to give 7-bromo-2-[o-imino-(4-thiazolidinone)- phenyl]-3-imino-(4 thiazolidinone)-Quinazolin-4(3H)-one (2). These Compounds were evaluated for their antibacterial activity (against some gram positive and gram negative microorganism) and antifungal activity (against Candida albicans). Study Design: This study was experimentally design and the antibacterial activity was evaluated against some microorganism, Staphylococcus aureus, Bacillus species, Aspergillus Species, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, and candida albicans.
Result
The compounds exhibited significant antibacterial activity with a zone of inhibition in the range of 10 – 20 mm in comparison to control.
Conclusions
From our findings, the compounds synthesized have higher antibacterial activities against Staphylococcus aureus, Aspergillus Species, as compared to Ciprofloxicin (CPX) and Ketonaxol (PEF) standard antibacterial drugs.
Zitieren
APA
Osarumwense, O. P., & Bamidele, T. G. (2026). Fusion and Bacterialcidal Activity of 7-bromo-2-(o-aminophenyl)- 3-amino-Quinazolin-4(3H)-one from 7-bromo,2-(o-aminophenyl)- 1,3-benzoxazin-4(3H)-one. Healthcare Issues. https://doi.org/10.58614/hi522
Vancouver
Osarumwense OP, Bamidele TG. Fusion and Bacterialcidal Activity of 7-bromo-2-(o-aminophenyl)- 3-amino-Quinazolin-4(3H)-one from 7-bromo,2-(o-aminophenyl)- 1,3-benzoxazin-4(3H)-one. Healthcare Issues. 2026. doi:10.58614/hi522
BibTeX
@article{Osarumwense2026,
author = {Osarumwense, Osarodion Peter and Bamidele, Tunmise Gideon},
title = {Fusion and Bacterialcidal Activity of 7-bromo-2-(o-aminophenyl)- 3-amino-Quinazolin-4(3H)-one from 7-bromo,2-(o-aminophenyl)- 1,3-benzoxazin-4(3H)-one},
journal = {Healthcare Issues},
year = {2026},
doi = {10.58614/hi522}
}
EUVIMED